Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Black CL, Muok EM, Mwinzi PN, Carter JM, Karanja DM, Secor WE, Colley DG.

J Infect Dis. 2010 Aug 15;202(3):399-405. doi: 10.1086/653828.

2.

Immunity and morbidity in human schistosomiasis mansoni.

Butterworth AE, Curry AJ, Dunne DW, Fulford AJ, Kimani G, Kariuki HC, Klumpp R, Koech D, Mbugua G, Ouma JH, et al.

Trop Geogr Med. 1994;46(4 Spec No):197-208. Review.

PMID:
7825222
3.

Immunity and morbidity in Schistosoma mansoni infection: quantitative aspects.

Butterworth AE, Dunne DW, Fulford AJ, Ouma JH, Sturrock RF.

Am J Trop Med Hyg. 1996 Nov;55(5 Suppl):109-15. Review.

PMID:
8940963
4.

Human schistosomiasis in the post mass drug administration era.

Mutapi F, Maizels R, Fenwick A, Woolhouse M.

Lancet Infect Dis. 2017 Feb;17(2):e42-e48. doi: 10.1016/S1473-3099(16)30475-3. Epub 2016 Dec 15. Review.

PMID:
27988094

Supplemental Content

Support Center